GSK recalls 600,000 Ventolin Inhalers from US

GSK recalls 600,000 Ventolin Inhalers from US

Multinational pharmaceutical company, GlaxoSmithKline (GSK) has announced the recall of over 590,000 Salbutamol  (Ventolin) inhalers from the US market, saying there could be issues with the delivery technique.

The recall is for three lots of Ventolin HFA 200D inhalers with lot numbers 6ZP0003, 6ZP9944 and 6ZP9848.

The inhalers, according to reports,  have been distributed to hospitals, pharmacies, retailers and wholesalers in the United States.

“There is attainable risk that the affected inhalers could potentially not deliver the stated number of actuations,” according to GSK spokesman Juan Carlos Molina. “We continue to investigate the situation in order to identify the root lead to and implement appropriate corrective and preventative actions.”

The recall is not directed at individuals, but those with inhalers from the recalled lots have been advised to contact the company.

About author

You might also like

Cancer: Why women need to embrace healthy habits, early detection – Oncology

A Senior Registrar at the Department of Radiation Oncology, Lagos University Teaching Hospital (LUTH), Dr Victor Isibor, has charged women to desist from harmful behaviours like smoking, excessive alcohol intake

Isolation or quarantine? NCDC confused over word to describe DG’s condition

The Nigeria Centre for Disease Control (NCDC) momentarily lost its path finding role in the ongoing COVID-19 crisis yesterday as it failed to work out the appropriate term to describe

Stakeholders laud UNODC as ‘Support to Justice Sector in Nigeria’ Project ends

New EU ‘successor project’ takes off ABUJA – The United Nations Office for Drugs and Crime (UNODC)  formally ended its five-year ‘Support to Justice Sector in Nigeria’ project today  amid

0 Comments

No Comments Yet!

You can be first to comment this post!

Leave a Reply